| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |